Protocol of a comparative multicentric non inferiority clinical trial of WHO MBMDT with a new monthly chemotherapy regimen containing rifampicin, moxifloxacin and clarithromycin (RMC) on multibacillary patients from India
Results will be submitted for publication in peer-reviewed journals. Ethical approval has been obtained from The Leprosy Mission Trust India's ethics committee (TLMTI/EC/C-69). This study is registered at Clinical Trials Registry-India (CTRI) - CTRI/2024/03/064435.
Authors
- Utpal Sengupta (ORCID: https://orcid.org/0000-0002-1177-1076)
- Samrun Nessa
- Neeta Maximus
- Ann Miriam Jose
- Joydeepa Darlong (ORCID: https://orcid.org/0000-0002-3242-8875)
- Sylvia Jayakumar
- Anamika Haldar
- Vandana Elkana
- Itu Singh
- Kartikeyan Govindasamy
- Reeta Devi
Institutions
- The Leprosy Mission International (GB)
- Schieffelin Institute of Health Research and Leprosy Centre (IN)
- Statistical Service (CY)
- Statistical Research (United States) (US)
Publication Details
- Journal
- Trials
- Published
- 2026-02-17
- DOI
- https://doi.org/10.1186/s13063-026-09544-3
- Primary Topic
- Leprosy Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00